COVID-19 and Illicit Markets

In this event, a panel of leading experts on illicit markets and harm reduction discussed the potential impact of COVID-19 on drug markets, policymakers and people who use drugs.

Speakers

 

Naomi-Burke-Shyne-200x200

Naomi Burke-Shyne is the Executive Director of Harm Reduction International. She has more than 10 years of international experience at the intersection of harm reduction, HIV and human rights. She is a member of the Strategic Advisory Group to the UN on HIV and Drug Use, a member of the Global Fund Technical Review Panel for Human Rights and Gender, and a member of the World Health Organization Guidelines Group on 'Ensuring Balance in National Policies on Controlled Substances'.

Jason-Eligh-200x200

Jason Eligh is a Senior Expert at the Global Inititative Against Transnational Organized Crime. He is an illicit drug market and policy analyst who has researched, developed and led technical cooperation and assistance initiatives addressing influencing drug use behaviours and the structural resilience of drug trade environments, particularly as these factors relate to the development and sustainability of harm. to the UN on HIV and Drug Use, a member of the Global Fund Technical Review Panel for Human Rights and Gender, and a member of the World Health Organization Guidelines Group on 'Ensuring Balance in National Policies on Controlled Substances'.

Gabriel-Feltran-200x200

Gabriel Feltran is a professor in the Department of Sociology at the Federal University of São Carlos in Brazil, and currently Senior Researcher at the Brazilian Centre for Planning and Analysis (CEBRAP). His current research looks at criminal groups and illegal markets in Brazil, focussing on collective action, marginalized groups and "the criminal world" in São Paulo.

Kasia-Malinowska-200x200

Kasia Malinowska is the director of the Global Drug Policy Program at the Open Society Foundations. She previously led the Open Society’s International Harm Reduction Development program, which supports the health and human rights of people who use drugs. She publishes regularly on drug policy as it relates to women, social justice, health, human rights, civil society, and governance, and she co-authored Poland’s first National AIDS program and has helped formulate policy in international organisations.

alex-soderholm-200x200

Alexander Söderholm is the Policy Coordinator of the LSE International Drug Policy Unit (IDPU), and the Managing Editor of the Journal of Illicit Economies and Development. He is currently a PhD Candidate in Social Policy at the LSE with a research project titled 'Drugs, Livelihoods, and Development: The Role of Illicit Markets in Determining Development Outcomes'. He has also worked with the United Nations Office on Drugs and Crime (UNODC) in Iran and has conducted research and policy work in a number of countries, such as Thailand, Myanmar, South Africa, Colombia, and Brazil, on issues related to illicit markets and sustainable development.

Chair

john-collins-1x1

John Collins is Executive Director of the LSE’s International Drug Policy Unit (IDPU), a Fellow of the LSE US Centre and a Distinguished Visiting Fellow of the Yale Centre for the Study of Globalization. He is Editor-in-Chief of the Journal of Illicit Economies and Development (JIED), an Open Access journal published by LSE Press.

 

Podcast and Video

This event was held on 02 June 2020

Check back later for our latest Twitter updates.

Contact us

Telephone

Telephone +44 (0)207 955 6938

Email

Email uscentre@lse.ac.uk

Address

Phelan LSE US Centre, Centre Building, 10th Floor, , 2 Houghton Street, London, WC2A 2AD